Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Comparison Tests

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibition of mitochondrial ROS by TACI sustains bone marrow plasma cells.

Nature communications·2026

Same author

STING agonist protects against exacerbation of schistosome egg-induced immunopathology.

PLoS pathogens·2026

Same author

Core-shell commensal biocapsules for <i>in situ</i> gut microbiome engineering.

Bioactive materials·2026

Same author

Reversible coma and elevated central venous pressure: warning signs of acute superior vena cava graft thrombosis following Warden procedure: a case report.

BMC anesthesiology·2026

Same author

CHST5 gene mutations contribute to high myopia by disrupting collagen fiber organization.

Journal of genetics and genomics = Yi chuan xue bao·2026

Same author

Expert consensus on treatment of condylar hyperplasia and secondary dento-maxillofacial deformities.

International journal of oral science·2026

Search research articles

Related Experiment Video

Updated: Jul 25, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

UGM: a more stable procedure for large-scale multiple testing problems, new solutions to identify oncogene.

Chengyou Liu¹, Leilei Zhou¹, Yuhe Wang¹

¹Department of Medical Engineering, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Theoretical Biology & Medical Modelling

|December 24, 2019

Summary

A new Unit Gamma Measurement (UGM) method improves gene expression analysis in tumors. UGM offers greater accuracy and efficiency in identifying disease-associated genes from high-throughput sequencing data.

Keywords:

Cancer-associated genes Differentially expressed genes False discovery rate RNA-Seq data Root mean square error Standard deviation

More Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Experiment Videos

Last Updated: Jul 25, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Area of Science:

Genomics
Bioinformatics
Cancer Research

Background:

Gene expression variations are crucial in tumor development.
Current methods for identifying differentially expressed genes in high-throughput sequencing face challenges with large datasets, including high standard deviation in false discovery rate (FDR) and increasing type I errors.
Existing algorithms struggle with dependency issues when detecting numerous genes.

Purpose of the Study:

To develop a novel method, Unit Gamma Measurement (UGM), to address the limitations of existing gene expression analysis techniques.
To improve the accuracy and robustness of identifying differentially expressed genes, particularly in the context of cancer research.
To reduce the dependency problem inherent in multiple hypothesis testing for large-scale genomic data.

Main Methods:

Developed the Unit Gamma Measurement (UGM) method, which accounts for the distribution of multiple hypothesis test statistics.
Utilized simulated gene expression profile data for initial testing and validation.
Applied UGM to real-world breast cancer RNA-Seq data to assess its performance on actual biological samples.

Main Results:

UGM demonstrated high accuracy, with the number of non-differentially expressed genes identified closely matching real-evidence data.
The UGM method exhibited a smaller standard error, range, quartile range, and Root Mean Square (RMS) error compared to existing methods.
UGM successfully screened several breast cancer-associated genes, including BRCA1, BRCA2, PTEN, and BRIP1.

Conclusions:

The Unit Gamma Measurement (UGM) provides a more accurate, robust, and efficient approach for identifying differentially expressed genes in high-throughput sequencing.
UGM effectively mitigates the dependency problem in multiple hypothesis testing, leading to more reliable results.
This method holds significant potential for advancing cancer gene discovery and understanding tumor biology.